Published in Am J Pathol on February 01, 2011
The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma. Nat Rev Gastroenterol Hepatol (2011) 1.26
CD133/Src axis mediates tumor initiating property and epithelial-mesenchymal transition of head and neck cancer. PLoS One (2011) 1.23
Reproductive history and breast cancer risk. Breast Cancer (2012) 1.14
Matricellular proteins: a sticky affair with cancers. J Oncol (2012) 1.10
Histone demethylase RBP2 is critical for breast cancer progression and metastasis. Cell Rep (2014) 1.04
Binding of αvβ1 and αvβ6 integrins to tenascin-C induces epithelial-mesenchymal transition-like change of breast cancer cells. Oncogenesis (2013) 0.95
Targeting ECM Disrupts Cancer Progression. Front Oncol (2015) 0.92
How integrins control breast biology. Curr Opin Cell Biol (2013) 0.89
Tenascin-C and mechanotransduction in the development and diseases of cardiovascular system. Front Physiol (2014) 0.86
Cadherin 6 is a new RUNX2 target in TGF-β signalling pathway. PLoS One (2013) 0.86
Barium promotes anchorage-independent growth and invasion of human HaCaT keratinocytes via activation of c-SRC kinase. PLoS One (2011) 0.85
Lung fibrotic tenascin-C upregulation is associated with other extracellular matrix proteins and induced by TGFβ1. BMC Pulm Med (2014) 0.85
Tenascin-C and integrins in cancer. Cell Adh Migr (2015) 0.82
Potentiation of tumor cell invasion by co-culture with monocytes accompanying enhanced production of matrix metalloproteinase and fibronectin. Clin Exp Metastasis (2012) 0.82
Expression of core 3 synthase in human pancreatic cancer cells suppresses tumor growth and metastasis. Int J Cancer (2013) 0.82
Atrial natriuretic peptide exerts protective action against angiotensin II-induced cardiac remodeling by attenuating inflammation via endothelin-1/endothelin receptor A cascade. Heart Vessels (2013) 0.82
Tenascin C in metastasis: A view from the invasive front. Cell Adh Migr (2015) 0.81
Failure of anti tumor-derived endothelial cell immunotherapy depends on augmentation of tumor hypoxia. Oncotarget (2014) 0.79
PDGF and TGF-β promote tenascin-C expression in subepithelial myofibroblasts and contribute to intestinal mucosal protection in mice. Br J Pharmacol (2014) 0.79
Down-regulation of CD9 by methylation decreased bortezomib sensitivity in multiple myeloma. PLoS One (2014) 0.78
Stromal proteome expression profile and muscle-invasive bladder cancer research. Cancer Cell Int (2012) 0.77
Migration of breast cancer cell lines in response to pulmonary laminin 332. Cancer Med (2016) 0.75
Parametric analysis of colony morphology of non-labelled live human pluripotent stem cells for cell quality control. Sci Rep (2016) 0.75
Tenascin C and its modulatory role in tumor progression in systemic malignancies. Cytotechnology (2013) 0.75
Effluent Tenascin-C Levels Reflect Peritoneal Deterioration in Peritoneal Dialysis: MAJOR IN PD Study. Biomed Res Int (2015) 0.75
WT1 expression in breast cancer disrupts the epithelial/mesenchymal balance of tumour cells and correlates with the metabolic response to docetaxel. Sci Rep (2017) 0.75
Tumor microenvironment tenascin-C promotes glioblastoma invasion and negatively regulates tumor proliferation. Neuro Oncol (2015) 0.75
Tenascin-C and fibronectin in normal esophageal mucosa, Barrett's esophagus, dysplasia and adenocarcinoma. Oncotarget (2017) 0.75
Epithelial-mesenchymal transitions in development and disease. Cell (2009) 39.17
Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer (2007) 18.69
Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell (2008) 14.80
Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol (2005) 11.46
Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol (1997) 11.36
Biomarkers for epithelial-mesenchymal transitions. J Clin Invest (2009) 8.76
Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res (2006) 5.90
The role of focal-adhesion kinase in cancer - a new therapeutic opportunity. Nat Rev Cancer (2005) 5.57
Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem (2000) 5.00
Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition. Bioessays (2001) 4.73
Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? Cancer Res (2005) 3.78
The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res (2005) 3.65
Src kinase regulation by phosphorylation and dephosphorylation. Biochem Biophys Res Commun (2005) 3.31
Epithelial mesenchymal transition traits in human breast cancer cell lines. Clin Exp Metastasis (2008) 2.86
Palate development. Development (1988) 2.80
Transitions between epithelial and mesenchymal states in development and disease. Semin Cell Dev Biol (2008) 2.69
Epithelial-mesenchymal transition and cell cooperativity in metastasis. Cancer Res (2009) 2.68
Mechanisms of metastasis: epithelial-to-mesenchymal transition and contribution of tumor microenvironment. J Cell Biochem (2007) 2.67
Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma. J Clin Invest (2005) 2.61
Inhibition of beta-catenin-mediated transactivation by cadherin derivatives. Proc Natl Acad Sci U S A (1998) 2.55
Src-induced de-regulation of E-cadherin in colon cancer cells requires integrin signalling. Nat Cell Biol (2002) 2.50
Induction by transforming growth factor-beta1 of epithelial to mesenchymal transition is a rare event in vitro. Breast Cancer Res (2004) 2.33
Tenascin-C induced signaling in cancer. Cancer Lett (2006) 2.21
Regulation of tenascin-C, a vascular smooth muscle cell survival factor that interacts with the alpha v beta 3 integrin to promote epidermal growth factor receptor phosphorylation and growth. J Cell Biol (1997) 2.16
Site-restricted expression of cytotactin during development of the chicken embryo. J Cell Biol (1986) 1.95
Molecular and pathological signatures of epithelial-mesenchymal transitions at the cancer invasion front. Histochem Cell Biol (2008) 1.91
Src and FAK signalling controls adhesion fate and the epithelial-to-mesenchymal transition. Curr Opin Cell Biol (2005) 1.85
Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor. J Cell Biol (2001) 1.74
Targeting Src in breast cancer. Ann Oncol (2008) 1.57
Cell adhesion molecule L1 disrupts E-cadherin-containing adherens junctions and increases scattering and motility of MCF7 breast carcinoma cells. Cancer Res (2006) 1.49
Identification of VEGF-regulated genes associated with increased lung metastatic potential: functional involvement of tenascin-C in tumor growth and lung metastasis. Oncogene (2008) 1.48
Identification of Src-specific phosphorylation site on focal adhesion kinase: dissection of the role of Src SH2 and catalytic functions and their consequences for tumor cell behavior. Cancer Res (2005) 1.45
Tenascin expression in cancer cells and stroma of human breast cancer and its prognostic significance. Clin Cancer Res (1995) 1.40
Tenascin-C expression in invasion border of early breast cancer: a predictor of local and distant recurrence. Br J Cancer (1998) 1.32
Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase-dependent and independent mechanisms. Breast Cancer Res (2009) 1.28
Tenascin-C upregulates matrix metalloproteinase-9 in breast cancer cells: direct and synergistic effects with transforming growth factor beta1. Int J Cancer (2003) 1.21
Tenascin-C suppresses Rho activation. J Cell Biol (2000) 1.20
Altered regulation of Src upon cell detachment protects human lung adenocarcinoma cells from anoikis. Oncogene (2004) 1.20
An immunohistochemical examination of the expression of E-cadherin, alpha- and beta/gamma-catenins, and alpha2- and beta1-integrins in invasive breast cancer. J Pathol (1999) 1.20
Breast cancer progression: controversies and consensus in the molecular mechanisms of metastasis and EMT. J Mammary Gland Biol Neoplasia (2007) 1.18
Expression of beta-catenin in normal breast tissue and breast carcinoma: a comparative study with epithelial cadherin and alpha-catenin. Histopathology (1996) 1.15
E-cadherin as a prognostic indicator in primary breast cancer. Br J Cancer (2001) 1.15
Involvement of large tenascin-C splice variants in breast cancer progression. Am J Pathol (2003) 1.12
Stromal fibroblasts from the interface zone of human breast carcinomas induce an epithelial-mesenchymal transition-like state in breast cancer cells in vitro. J Cell Sci (2010) 1.10
Epithelial-mesenchymal transformation in the embryonic heart is mediated through distinct pertussis toxin-sensitive and TGFbeta signal transduction mechanisms. Dev Dyn (1999) 1.05
Formation and early morphogenesis of endocardial endothelial precursor cells and the role of endoderm. Dev Biol (1996) 1.01
Expression of tenascin-C in intraductal carcinoma of human breast: relationship to invasion. Eur J Cancer (1998) 1.00
Growth promoting signaling by tenascin-C [corrected]. Cancer Res (2004) 0.99
Expression of P-cadherin, but not E-cadherin or N-cadherin, relates to pathological and functional differentiation of breast carcinomas. Mol Pathol (2003) 0.99
Expression of tenascin in invasion border of early breast cancer correlates with higher risk of distant metastasis. Int J Cancer (1996) 0.99
Involvement of tenascin-C in proliferation and migration of laryngeal carcinoma cells. Virchows Arch (1999) 0.97
Co-expression of tenascin and fibronectin in epithelial and stromal cells of benign lesions and ductal carcinomas in the human breast. J Pathol (1997) 0.95
Tenascin-C signaling through induction of 14-3-3 tau. J Cell Biol (2003) 0.94
Analysis of tenascin mRNA expression in the murine mammary gland from embryogenesis to carcinogenesis: an in situ hybridization study. Int J Dev Biol (1997) 0.93
Enhanced tenascin-C expression and matrix deposition during Ras/TGF-beta-induced progression of mammary tumor cells. Oncogene (2004) 0.90
Gene expression and protein deposition of major basement membrane components and TGF-beta 1 in human breast cancer. Anticancer Res (1998) 0.87
Mammary epithelial cell differentiation in vitro is regulated by an interplay of EGF action and tenascin-C downregulation. J Cell Sci (1995) 0.85
The expression of tenascin by neural crest cells and glia. Development (1991) 0.85
Human carcinoma cells synthesize and secrete tenascin in vitro. Jpn J Cancer Res (1992) 0.81
Targeted deletion of BMK1/ERK5 in adult mice perturbs vascular integrity and leads to endothelial failure. J Clin Invest (2004) 2.76
Features of early gastric cancer and gastric adenoma by enhanced-magnification endoscopy. J Gastroenterol (2006) 1.75
Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction. Am J Physiol Heart Circ Physiol (2003) 1.74
Different mechanisms of development and maintenance of experimental incision-induced hyperalgesia in human skin. Anesthesiology (2002) 1.59
Tenascin-C synthesized in both donor grafts and recipients accelerates artery graft stenosis. Cardiovasc Res (2007) 1.48
Esophageal anthracosis: lesion mimicking malignant melanoma. Pathol Int (2002) 1.46
Tenascin-C regulates recruitment of myofibroblasts during tissue repair after myocardial injury. Am J Pathol (2005) 1.46
Method of cell transplantation promoting the organization of intraarterial thrombus. Circulation (2005) 1.40
Pitavastatin regulates helper T-cell differentiation and ameliorates autoimmune myocarditis in mice. Cardiovasc Drugs Ther (2013) 1.38
Co-stimulation of human breast cancer cells with transforming growth factor-beta and tenascin-C enhances matrix metalloproteinase-9 expression and cancer cell invasion. Int J Exp Pathol (2004) 1.33
Survival of geriatric patients after percutaneous endoscopic gastrostomy in Japan. World J Gastroenterol (2010) 1.30
Discrepancy between local and central pathological review of radical prostatectomy specimens. J Urol (2010) 1.24
The impact of baseline [-2]proPSA-related indices on the prediction of pathological reclassification at 1 year during active surveillance for low-risk prostate cancer: the Japanese multicenter study cohort. J Cancer Res Clin Oncol (2013) 1.22
Role of stromal myofibroblasts in invasive breast cancer: stromal expression of alpha-smooth muscle actin correlates with worse clinical outcome. Breast Cancer (2010) 1.21
Tenascin-C upregulates matrix metalloproteinase-9 in breast cancer cells: direct and synergistic effects with transforming growth factor beta1. Int J Cancer (2003) 1.21
Human equilibrative nucleoside transporter 1 expression is a strong independent prognostic factor in UICC T3-T4 pancreatic cancer patients treated with preoperative gemcitabine-based chemoradiotherapy. J Hepatobiliary Pancreat Sci (2012) 1.20
Reduction of visceral fat is associated with decrease in the number of metabolic risk factors in Japanese men. Diabetes Care (2007) 1.20
Genetic analysis of noroviruses in Chiba Prefecture, Japan, between 1999 and 2004. J Clin Microbiol (2005) 1.19
Molecular epidemiological analyses of Japanese encephalitis virus isolates from swine in Japan from 2002 to 2004. J Gen Virol (2007) 1.19
A nuclear factor-kappaB inhibitor pyrrolidine dithiocarbamate ameliorates pulmonary hypertension in rats. Chest (2007) 1.19
A crucial role of mitochondrial Hsp40 in preventing dilated cardiomyopathy. Nat Med (2005) 1.19
Relationship between the serum uric acid level, visceral fat accumulation and serum adiponectin concentration in Japanese men. Intern Med (2008) 1.18
Meiotic recombination-related DNA synthesis and its implications for cross-over and non-cross-over recombinant formation. Proc Natl Acad Sci U S A (2007) 1.18
Altered methylation of multiple genes in carcinogenesis of the prostate. Int J Cancer (2003) 1.18
Somatostatinoma of the papilla of Vater with multiple gastrointestinal stromal tumors in a patient with von Recklinghausen's disease. J Gastroenterol (2002) 1.17
Experimental incision-induced pain in human skin: effects of systemic lidocaine on flare formation and hyperalgesia. Pain (2002) 1.17
Tenascin-C is a useful marker for disease activity in myocarditis. J Pathol (2002) 1.16
Intravascular large B-cell lymphoma presenting with mass lesions in the central nervous system: a report of five cases. Pathol Int (2004) 1.14
Malignant phyllodes tumor of the prostate: retrospective review of specimens obtained by sequential transurethral resection. Pathol Int (2002) 1.14
The mitotic DNA damage checkpoint proteins Rad17 and Rad24 are required for repair of double-strand breaks during meiosis in yeast. Genetics (2003) 1.12
The targeted disruption of the MYPT1 gene results in embryonic lethality. Transgenic Res (2005) 1.12
Involvement of large tenascin-C splice variants in breast cancer progression. Am J Pathol (2003) 1.12
Characterization and function of MYPT2, a target subunit of myosin phosphatase in heart. Cell Signal (2006) 1.11
Three-dimensional cellular spheroid formation provides human prostate tumor cells with tissue-like features. Anticancer Res (2007) 1.10
The targeted disruption of the CD98 gene results in embryonic lethality. Biochem Biophys Res Commun (2003) 1.10
Improved photovoltaic performance of silicon nanowire/organic hybrid solar cells by incorporating silver nanoparticles. Nanoscale Res Lett (2013) 1.08
Tenascin-C may aggravate left ventricular remodeling and function after myocardial infarction in mice. Am J Physiol Heart Circ Physiol (2010) 1.08
Serum tenascin-C might be a novel predictor of left ventricular remodeling and prognosis after acute myocardial infarction. J Am Coll Cardiol (2006) 1.07
Noradrenalin-secreting retroperitoneal schwannoma resected by hand-assisted laparoscopic surgery: report of a case. Surg Today (2006) 1.07
Inhibition of Rho family GTPases by Rho GDP dissociation inhibitor disrupts cardiac morphogenesis and inhibits cardiomyocyte proliferation. Development (2002) 1.05
HER2-specific T-cell immune responses in patients vaccinated with truncated HER2 protein complexed with nanogels of cholesteryl pullulan. Clin Cancer Res (2006) 1.05
Eplerenone attenuates myocardial fibrosis in the angiotensin II-induced hypertensive mouse: involvement of tenascin-C induced by aldosterone-mediated inflammation. J Cardiovasc Pharmacol (2007) 1.05
T-box 2, a mediator of Bmp-Smad signaling, induced hyaluronan synthase 2 and Tgfbeta2 expression and endocardial cushion formation. Proc Natl Acad Sci U S A (2009) 1.04
Thrombin-cleaved osteopontin levels in synovial fluid correlate with disease severity of knee osteoarthritis. J Rheumatol (2010) 1.04
Matricellular proteins: new molecular targets to prevent heart failure. Cardiovasc Ther (2011) 1.04
Pretreatment serum testosterone level as a predictive factor of pathological stage in localized prostate cancer patients treated with radical prostatectomy. Eur Urol (2004) 1.03
The dynamic expression of tenascin-C and tenascin-X during early heart development in the mouse. Differentiation (2003) 1.03
A peptide derived from tenascin-C induces beta1 integrin activation through syndecan-4. J Biol Chem (2007) 1.02
Health education "Hokenshido" program reduced metabolic syndrome in the Amagasaki visceral fat study. Three-year follow-up study of 3,174 Japanese employees. Intern Med (2011) 1.02
Usefulness of breast-volume replacement using an inframammary adipofascial flap after breast-conservation therapy. Am J Surg (2007) 1.01
Tenascin-C enhances crosstalk signaling of integrin αvβ3/PDGFR-β complex by SRC recruitment promoting PDGF-induced proliferation and migration in smooth muscle cells. J Cell Physiol (2011) 1.01
Genetic polymorphisms of hormone-related genes and prostate cancer risk in the Japanese population. Anticancer Res (2004) 1.00
Interleukin-1 receptor antagonist inhibits the expression of vascular endothelial growth factor in colorectal carcinoma. Oncology (2005) 1.00
Gleason score correlation between biopsy and prostatectomy specimens and prediction of high-grade Gleason patterns: significance of central pathologic review. Urology (2010) 0.99
Categorization of non-mass-like breast lesions detected by MRI. Breast Cancer (2008) 0.99
Humoral immune responses in patients vaccinated with 1-146 HER2 protein complexed with cholesteryl pullulan nanogel. Cancer Sci (2007) 0.99
Xrs2p regulates Mre11p translocation to the nucleus and plays a role in telomere elongation and meiotic recombination. Mol Biol Cell (2004) 0.99
MRI appearance of prostatic stromal sarcoma in a young adult. Korean J Radiol (2011) 0.96
Pathological findings at radical prostatectomy in Japanese prospective active surveillance cohort. Jpn J Clin Oncol (2010) 0.96
Higher serum tenascin-C levels reflect the severity of heart failure, left ventricular dysfunction and remodeling in patients with dilated cardiomyopathy. Circ J (2007) 0.96
4-year follow-up of cardiovascular events and changes in visceral fat accumulation after health promotion program in the Amagasaki Visceral Fat Study. Atherosclerosis (2010) 0.96
Expression of large tenascin-C splice variants in synovial fluid of patients with rheumatoid arthritis. J Orthop Res (2007) 0.96
Complete genomes and phylogenetic positions of bovine papillomavirus type 8 and a variant type from a European bison. Virus Genes (2007) 0.95
Relationship between visceral fat accumulation and urinary albumin-creatinine ratio in middle-aged Japanese men. Atherosclerosis (2010) 0.95
Absolute value of bioelectrical impedance analysis-measured visceral fat area with obesity-related cardiovascular risk factors in Japanese workers. J Atheroscler Thromb (2010) 0.95
Condensin loaded onto the replication fork barrier site in the rRNA gene repeats during S phase in a FOB1-dependent fashion to prevent contraction of a long repetitive array in Saccharomyces cerevisiae. Mol Cell Biol (2006) 0.94
MMP-2 expression is associated with rapidly proliferative arteriosclerosis in the flexor tenosynovium and pain severity in carpal tunnel syndrome. J Pathol (2005) 0.93
Adenovirus type 5 substituted with type 11 or 35 fiber structure increases its infectivity to human cells enabling dual gene transfer in CD46-dependent and -independent manners. Anticancer Res (2007) 0.93
High prevalence of chronic myocarditis in dilated cardiomyopathy referred for left ventriculoplasty: expression of tenascin C as a possible marker for inflammation. Hum Pathol (2009) 0.92
Antibody responses against NY-ESO-1 and HER2 antigens in patients vaccinated with combinations of cholesteryl pullulan (CHP)-NY-ESO-1 and CHP-HER2 with OK-432. Vaccine (2009) 0.92
Deficiency of tenascin C attenuates allergen-induced bronchial asthma in the mouse. Eur J Immunol (2006) 0.92
Changes in serum adiponectin concentrations correlate with changes in BMI, waist circumference, and estimated visceral fat area in middle-aged general population. Diabetes Care (2009) 0.91
Usefulness of immunohistochemistry for differential diagnosis between benign and malignant breast lesions. Breast Cancer (2009) 0.91
Long-term results of breast volume replacement using an inframammary adipofascial flap after breast-conserving surgery. Breast Cancer (2011) 0.91
Imatinib mesylate prevents cerebral vasospasm after subarachnoid hemorrhage via inhibiting tenascin-C expression in rats. Neurobiol Dis (2012) 0.91
Sae2p phosphorylation is crucial for cooperation with Mre11p for resection of DNA double-strand break ends during meiotic recombination in Saccharomyces cerevisiae. Genes Genet Syst (2008) 0.90
α9β1 integrin-mediated signaling serves as an intrinsic regulator of pathogenic Th17 cell generation. J Immunol (2011) 0.90
Detection of experimental autoimmune myocarditis in rats by 111In monoclonal antibody specific for tenascin-C. Circulation (2002) 0.90